Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Honoraria | $11,710 | 5 | 42.6% |
| Food and Beverage | $10,174 | 549 | 37.0% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $2,310 | 1 | 8.4% |
| Travel and Lodging | $2,065 | 15 | 7.5% |
| Consulting Fee | $1,040 | 1 | 3.8% |
| Education | $178.16 | 3 | 0.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Alexion Pharmaceuticals, Inc. | $18,281 | 52 | $0 (2024) |
| ABBVIE INC. | $1,004 | 78 | $0 (2024) |
| UCB, Inc. | $792.29 | 36 | $0 (2024) |
| UPSHER-SMITH LABORATORIES LLC | $696.63 | 44 | $0 (2023) |
| Teva Pharmaceuticals USA, Inc. | $627.19 | 35 | $0 (2024) |
| Biogen, Inc. | $536.49 | 31 | $0 (2023) |
| Mallinckrodt Hospital Products Inc. | $512.28 | 18 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $448.06 | 26 | $0 (2024) |
| PFIZER INC. | $323.33 | 25 | $0 (2024) |
| Kyowa Kirin, Inc. | $288.60 | 18 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,209 | 71 | UCB, Inc. ($228.86) |
| 2023 | $2,060 | 114 | ABBVIE INC. ($366.59) |
| 2022 | $2,860 | 163 | Mallinckrodt Hospital Products Inc. ($317.68) |
| 2021 | $2,377 | 135 | UPSHER-SMITH LABORATORIES LLC ($285.11) |
| 2020 | $1,807 | 42 | Alexion Pharmaceuticals, Inc. ($1,081) |
| 2019 | $3,957 | 28 | Alexion Pharmaceuticals, Inc. ($3,736) |
| 2018 | $13,193 | 20 | Alexion Pharmaceuticals, Inc. ($13,193) |
| 2017 | $13.78 | 1 | Alexion Pharmaceuticals, Inc. ($13.78) |
All Payment Transactions
574 individual payment records from CMS Open Payments — Page 1 of 23
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $17.49 | General |
| Category: Neurology | ||||||
| 12/13/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $19.32 | General |
| Category: Rare Disease | ||||||
| 12/11/2024 | Aucta Pharmaceuticals, Inc. | Motpoly XR (Drug) | Food and Beverage | In-kind items and services | $15.74 | General |
| Category: Central Nervous System | ||||||
| 12/10/2024 | UCB, Inc. | Zilbrysq (Drug) | Food and Beverage | In-kind items and services | $25.76 | General |
| Category: Neurology | ||||||
| 12/05/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $10.72 | General |
| Category: PAIN | ||||||
| 11/21/2024 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $26.72 | General |
| Category: Neurology | ||||||
| 11/20/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $38.30 | General |
| Category: Neuropsychiatry | ||||||
| 11/13/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $19.45 | General |
| Category: Neuropsychiatry | ||||||
| 11/05/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $21.90 | General |
| Category: Neurology | ||||||
| 11/01/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $11.40 | General |
| Category: NEUROSCIENCE | ||||||
| 11/01/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $5.81 | General |
| Category: NEUROSCIENCE | ||||||
| 10/18/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $14.21 | General |
| Category: NEUROSCIENCE | ||||||
| 10/17/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $14.39 | General |
| Category: PAIN | ||||||
| 10/16/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $6.95 | General |
| Category: PAIN | ||||||
| 10/09/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $9.36 | General |
| Category: NEUROSCIENCE | ||||||
| 09/26/2024 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $23.33 | General |
| Category: Neurology | ||||||
| 09/25/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $11.80 | General |
| Category: PAIN | ||||||
| 09/24/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $20.52 | General |
| Category: Neurology | ||||||
| 09/09/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $18.16 | General |
| Category: Central Nervous System | ||||||
| 09/06/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $7.45 | General |
| Category: NEUROSCIENCE | ||||||
| 09/05/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $16.88 | General |
| Category: Rare Disease | ||||||
| 08/29/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $8.45 | General |
| Category: NEUROSCIENCE | ||||||
| 08/23/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $9.78 | General |
| Category: NEUROSCIENCE | ||||||
| 08/15/2024 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $32.19 | General |
| Category: Neurology | ||||||
| 08/14/2024 | Vanda Pharmaceuticals Inc. | PONVORY (Drug) | Food and Beverage | In-kind items and services | $21.21 | General |
| Category: MULTIPLE SCLEROSIS | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 610 | 743 | $178,148 | $56,897 |
| 2022 | 9 | 647 | 777 | $170,461 | $61,675 |
| 2021 | 10 | 678 | 866 | $165,042 | $66,026 |
| 2020 | 13 | 647 | 747 | $144,872 | $55,854 |
All Medicare Procedures & Services
39 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 150 | 150 | $56,706 | $17,539 | 30.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 191 | 271 | $53,846 | $17,189 | 31.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 76 | 80 | $22,734 | $7,593 | 33.4% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 52 | 55 | $18,755 | $5,484 | 29.2% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 54 | 80 | $14,435 | $4,844 | 33.6% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 49 | 69 | $6,276 | $2,679 | 42.7% |
| 95816 | Measurement of brain wave activity (eeg), awake and drowsy | Facility | 2023 | 38 | 38 | $5,396 | $1,569 | 29.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 162 | 162 | $55,062 | $18,559 | 33.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 164 | 219 | $35,289 | $13,693 | 38.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 88 | 98 | $22,500 | $8,634 | 38.4% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 59 | 81 | $17,501 | $6,560 | 37.5% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 57 | 94 | $14,416 | $5,290 | 36.7% |
| 99221 | Initial hospital inpatient care per day, typically 30 minutes | Facility | 2022 | 59 | 61 | $13,053 | $4,648 | 35.6% |
| 95911 | Nerve conduction, 9-10 studies | Office | 2022 | 11 | 11 | $6,348 | $1,940 | 30.6% |
| 95816 | Measurement of brain wave activity (eeg), awake and drowsy | Facility | 2022 | 33 | 33 | $3,961 | $1,392 | 35.2% |
| 95885 | Needle measurement of electrical activity in arm or leg muscles, limited study | Office | 2022 | 14 | 18 | $2,331 | $957.50 | 41.1% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 128 | 128 | $42,368 | $15,597 | 36.8% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 138 | 175 | $25,725 | $11,197 | 43.5% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 100 | 186 | $26,778 | $10,748 | 40.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 71 | 81 | $17,415 | $7,974 | 45.8% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 58 | 84 | $17,150 | $6,724 | 39.2% |
| 99221 | Initial hospital inpatient care, typically 30 minutes per day | Facility | 2021 | 73 | 79 | $15,818 | $6,365 | 40.2% |
| 95910 | Nerve transmission studies, 7-8 studies | Office | 2021 | 16 | 16 | $7,504 | $2,402 | 32.0% |
| 95816 | Measurement and recording of brain wave (eeg) activity, awake and drowsy | Facility | 2021 | 49 | 50 | $5,701 | $2,287 | 40.1% |
| 95885 | Needle measurement and recording of electrical activity of muscles of arm or leg limited study | Office | 2021 | 16 | 27 | $3,348 | $1,490 | 44.5% |
About Dr. Reginald Hall, MD
Dr. Reginald Hall, MD is a Neurology healthcare provider based in Cumming, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/12/2006. The National Provider Identifier (NPI) number assigned to this provider is 1902885494.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Reginald Hall, MD has received a total of $27,477 in payments from pharmaceutical and medical device companies, with $1,209 received in 2024. These payments were reported across 574 transactions from 49 companies. The most common payment nature is "Honoraria" ($11,710).
As a Medicare-enrolled provider, Hall has provided services to 2,582 Medicare beneficiaries, totaling 3,133 services with total Medicare billing of $240,452. Data is available for 4 years (2020–2023), covering 39 distinct procedure/service records.
Practice Information
- Specialty Neurology
- Location Cumming, GA
- Active Since 01/12/2006
- Last Updated 03/07/2018
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1902885494
Products in Payments
- SOLIRIS (Drug) $16,943
- Soliris (Drug) $1,157
- UBRELVY (Drug) $866.61
- NURTEC ODT (Drug) $796.31
- Briviact (Drug) $717.60
- ACTHAR (Biological) $512.28
- TOSYMRA (Drug) $487.48
- KESIMPTA (Drug) $425.38
- TYSABRI (Biological) $403.04
- AJOVY (Biological) $386.21
- Aimovig (Biological) $230.51
- INGREZZA (Drug) $219.51
- AUBAGIO (Drug) $193.19
- NOURIANZ (Drug) $188.18
- Austedo XR (Drug) $146.92
- Horizant (Drug) $144.78
- EMGALITY (Drug) $143.40
- VYEPTI (Biological) $142.50
- ULTOMIRIS (Biological) $134.61
- ZEMBRACE SYMTOUCH (Drug) $128.47
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Cumming
Dr. Scott Cooper, M.d, M.D
Neurology — Payments: $359,131
Frank Puhalovich, M.d, M.D
Neurology — Payments: $36,663
Peter Futrell, M.d, M.D
Neurology — Payments: $35,071
Dr. Jorge Juncos, M.d, M.D
Neurology — Payments: $19,011
Bernard Drexinger, M.d, M.D
Neurology — Payments: $5,654
Dr. Joseph Mcnamara, D.c, D.C
Neurology